CA3224052A1 - Complement bovin pour veaux nouveau-nes - Google Patents

Complement bovin pour veaux nouveau-nes Download PDF

Info

Publication number
CA3224052A1
CA3224052A1 CA3224052A CA3224052A CA3224052A1 CA 3224052 A1 CA3224052 A1 CA 3224052A1 CA 3224052 A CA3224052 A CA 3224052A CA 3224052 A CA3224052 A CA 3224052A CA 3224052 A1 CA3224052 A1 CA 3224052A1
Authority
CA
Canada
Prior art keywords
supplement
neonatal
caffeine
bovine
dietary supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3224052A
Other languages
English (en)
Inventor
Nathan C. Upah
Aaron N. FRITCHEN
Dennis M. Mckilligan
Bradley W. KOLSTAD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Techmix LLC
Original Assignee
Techmix LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/351,598 external-priority patent/US20220387436A1/en
Application filed by Techmix LLC filed Critical Techmix LLC
Publication of CA3224052A1 publication Critical patent/CA3224052A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Abstract

La présente invention concerne de manière générale une préparation de complément alimentaire destinée à être administrée à des ruminants et, plus particulièrement, une formulation pour un complément bovin oral pour veaux nouveau-nés qui délivre de la caféine naturelle, sous une forme liquide stable de viscosité élevée et éventuellement des antioxydants et d'autres électrolytes. Une dose liquide de 10-40 ml du complément contenant de l'extrait de thé vert délivre une quantité concentrée de caféine d'environ 100 à 400 mg au veau nouveau-né.
CA3224052A 2021-06-18 2022-08-11 Complement bovin pour veaux nouveau-nes Pending CA3224052A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/351,598 US20220387436A1 (en) 2018-08-30 2021-06-18 Bovine supplement for neonatal calves
US17/351,598 2021-06-18
PCT/US2022/040059 WO2022266557A2 (fr) 2021-06-18 2022-08-11 Complément bovin pour veaux nouveau-nés

Publications (1)

Publication Number Publication Date
CA3224052A1 true CA3224052A1 (fr) 2022-12-22

Family

ID=84526576

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3224052A Pending CA3224052A1 (fr) 2021-06-18 2022-08-11 Complement bovin pour veaux nouveau-nes

Country Status (4)

Country Link
EP (1) EP4355111A2 (fr)
AU (1) AU2022291939A1 (fr)
CA (1) CA3224052A1 (fr)
WO (1) WO2022266557A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1610820E (pt) * 2003-04-04 2010-12-16 Novartis Ag Formulações de elevada concentração de anticorpos e proteínas
WO2005115473A2 (fr) * 2004-05-24 2005-12-08 Nutrinia Ltd. Aliment nutritionnel, composition, traitement et procede d'utilisation
AU2015234690B2 (en) * 2014-03-26 2019-08-29 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US11298357B2 (en) * 2018-08-30 2022-04-12 Techmix, Llc Bovine supplement for neonatal calves

Also Published As

Publication number Publication date
EP4355111A2 (fr) 2024-04-24
AU2022291939A1 (en) 2024-01-18
WO2022266557A3 (fr) 2023-03-02
WO2022266557A4 (fr) 2023-04-13
WO2022266557A2 (fr) 2022-12-22

Similar Documents

Publication Publication Date Title
US20030194423A1 (en) Composition for enhancing nutritional content of food
JP2006180812A (ja) ゼリー飲料
CA2468707C (fr) L'utilisation oligosaccharides non digestibles pour ameliorer la sante et la productivite de ruminants
TW201635920A (zh) 肌肉合成促進劑
US11298357B2 (en) Bovine supplement for neonatal calves
US7829593B2 (en) Glutamine-containing compositions and a method for increasing blood flow using same
CA3224052A1 (fr) Complement bovin pour veaux nouveau-nes
US20220387436A1 (en) Bovine supplement for neonatal calves
JP2001269135A (ja) 体タンパク質蓄積効率を亢進する栄養組成物
US9248155B2 (en) Supplement composition and method of use
JP6961569B2 (ja) 水分補給用剤
JP4918260B2 (ja) 液体混合飼料およびその製造方法
CN105918464A (zh) 一种低糖石榴汁酸奶
KR100461580B1 (ko) 간기능 유지 및 개선에 유용한 발효유 및 그 제조방법
RU2056113C1 (ru) Способ выращивания новорожденных телят
TW202408560A (zh) 一種組合物用於治療眼睛疾病之醫藥品用途
US9254304B2 (en) Supplement composition and methods of use
CN112602822A (zh) 一种用于解酒护肝的冷冻饮品及其制备方法
TW201825011A (zh) 蛋白質效率提升用之組成物
CN108850617A (zh) 一种抗病易消化仔猪浓缩饲料
NZ526114A (en) Compositions for animal treatment
CN108552313A (zh) 一种榴莲饮料及其制备方法
CN107828618A (zh) 一种保健白酒
JPH04141051A (ja) 家畜用液状ビタミン剤およびその製造方法
JP2007020584A (ja) カルシウム吸収促進作用を有する食酢飲料およびその製造方法